DalsnaFinance › IPOs › TransCode Therapeutics › IPO
Transcode Therapeutics, Inc. completed its initial public offering on NASDAQ on July 9, 2021, pricing at $4.00 a share.
| Ticker | RNAZ |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 9, 2021 |
| Offering price | $4.00 |
| Shares offered | 6,250,000 |
| Total raised | $25M |
Transcode Therapeutics, Inc. sold 6,250,000 shares at $4.00 each on NASDAQ. Multiplied out, that is $25 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $25 million total recorded for the deal.
Transcode Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Transcode Therapeutics, Inc.. This page is general information, not investment advice.